emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Valeant Pharmaceuticals International / EMO-FARM Sp zoo

No EMAT : 19942
Announced Date : 08/05/2009
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Valeant Pharmaceuticals International

Target : EMO-FARM Sp zoo
Country : Poland
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Founded in 1986, Emo-Farm sp. zoo produces medicinal products, medical devices, and cosmetics on the base of gel . > The company offers drugs in the areas of analgesic and anti-inflammatory gel;...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
  • Number of EMAT Reports / sub-sector « Personal Products » = 133
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
16/02/2009 Private Group Led By FORUM European Smallcaps Pulsion Medical Systems Germany * 19898
23/04/2008 Southern Cross Healthcare Group Heather Park Homes England ** 19880

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report